According to the latest data from the Hong Kong Stock Exchange, on October 17, Chairman and Executive Director Cai Dongchen increased his stake in CSPC PHARMA (01093) by 3 million shares at a price of HKD 8.81 per share, totaling HKD 26.43 million. After this acquisition, his total holdings are approximately 2.842 billion shares, representing a 24.67% ownership stake.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.